CLINICAL_TRIALS ClinicalTrials.gov record update

Phase Ib Trial of Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03095781
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:26.256110+00:00
Published At: 2023-12-05T00:00:00+00:00
Record Updated At: 2023-12-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Colorectal Adenocarcinoma", "Metastatic Pancreatic Adenocarcinoma", "Recurrent Colorectal Carcinoma", "Recurrent Pancreatic Carcinoma", "Stage III Colorectal Cancer", "Stage III Pancreatic Cancer", "Stage IIIA Colorectal Cancer", "Stage IIIB Colorectal Cancer", "Stage IV Colorectal Cancer", "Stage IV Pancreatic Cancer", "Stage IVA Colorectal Cancer", "Stage IVA Pancreatic Cancer", "Stage IVB Colorectal Cancer", "Stage IVB Pancreatic Cancer", "Unresectable Pancreatic Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-12-05"
protocolSection.identificationModule.nctId: "NCT03095781"
protocolSection.identificationModule.officialTitle: "Phase Ib Trial of Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Malignancies"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.